Introduction
The placenta, a remarkable organ unique to pregnancy, serves as a vital interface between mother and foetus. Its primary functions include facilitating nutrient and gas exchange while simultaneously acting as a formidable barrier against potentially harmful pathogens 4 . Despite its robust defensive mechanisms, certain microorganisms have evolved strategies to breach this barrier, leading to severe maternal and foetal health complications 13 . This article explores the intricate pathways through which infections can affect the human placenta, drawing on recent scientific findings and understanding.
The Placental Barrier: Structure and Function
The placenta's role in pregnancy extends far beyond its nutritional functions. It employs a sophisticated array of physical, cellular, and immunological defences to protect the developing foetus 11 . The placental barrier comprises multiple layers, including the syncytiotrophoblast, which is directly exposed to maternal blood, and underlying cytotrophoblasts and stromal tissues 16 . Collectively, these layers form a formidable obstacle against invading pathogens. Additionally, the maternal immune system plays a crucial role in this defence, maintaining a delicate balance between tolerance to foetal antigens and readiness to combat infections 10 .
Pathogen Categories and Infection Mechanisms
Despite these defences, various pathogens have developed mechanisms to penetrate the placental barrier and infect the foetus. These pathogens are typically categorised into three main groups: bacterial, viral, and parasitic. Each group employs distinct strategies to evade the immune responses at the maternal-foetal interface and ensure their transmission to the foetus.
Bacterial Infections
Bacterial pathogens such as Listeria monocytogenes and Treponema pallidum (the causative agent of syphilis) have been well documented in their ability to cross the placental barrier. L. monocytogenes, for instance, utilises surface proteins, primarily Internalin A (InlA), to bind E-cadherin on trophoblasts, triggering receptor-mediated endocytosis 8 . Once internalised, L. monocytogenes escapes the phagosome using listeriolysin O (LLO), replicates in the cytoplasm, and spreads cell-to-cell via ActA-mediated actin polymerisation . This mechanism enables the pathogen to breach the placental barrier, potentially reaching foetal tissues 7 . Once inside, it can evade immune responses and proliferate, leading to severe complications such as preterm birth and neonatal sepsis 13 . The disruption of the placental barrier by bacteria can also trigger inflammatory responses that harm both mother and foetus. Prevention and management strategies for bacterial infections include antibiotic treatment, proper food hygiene, and regular prenatal check-ups.
Viral Infections
Viral infections, particularly those caused by cytomegalovirus (CMV) and Zika virus, have evolved mechanisms to breach the placenta and cause congenital infections. After maternal infection, CMV spreads through the blood to the placenta where the virus enters trophoblasts via receptor binding, endocytosis, or membrane fusion, facilitated by the viral glycoprotein B (gB), Once inside, CMV hijacks the cellular machinery for replication. Infected trophoblasts spread the virus to adjacent cells, disrupting placental barrier function 14 . This process enables CMV to cross from infected placental cells to foetal circulation, potentially resulting in severe foetal complications such as hearing loss and developmental delays 15 . Similarly, Zika virus has been shown to cause significant neurological damage by crossing the placenta and infecting foetal neural tissues 1 . Prevention and management of viral infections often involve hygiene practices, mosquito control in endemic areas, and, when applicable, antiviral treatments.
Parasitic Infections
Parasitic infections, exemplified by Toxoplasma gondii , the causative agent of toxoplasmosis, can also invade the placenta through direct cellular invasion, infected immune cell transport, or paracellular routes, in which the parasite employs specialised proteins, notably ROP18 (rhoptry protein 18), to form a moving junction with host cell membranes, facilitating entry. T. gondii evades both maternal and foetal immune responses, enabling replication within placental cells 9 . This invasion can lead to severe outcomes such as miscarriage, stillbirth, and congenital defects 6 . Preventive measures include avoiding undercooked meat and cat litter, while management often involves antiparasitic medications when infection is detected.
Impact on Maternal and Fatal Health
Placental infections profoundly impact maternal and foetal health through multiple mechanisms. Maternally, infections can trigger systemic inflammation, vascular dysfunction, and uterine contractions, potentially leading to preeclampsia, preterm labour, and in severe cases, maternal sepsis and mortality 12 . Fetally, pathogens crossing the placenta can cause direct tissue damage, while placental dysfunction restricts nutrient and oxygen transfer, resulting in growth restriction. Infections during critical developmental periods may lead to congenital anomalies. The foetal inflammatory response can damage developing organs, particularly the rain. Additonally placental structural damage alters gene expression, and vascular changes which further compromise foetal development, and long-term consequences include developmental delays and increased susceptibility to diseases in adulthood 10 . This interconnected process underscores the critical need for prevention and early intervention in placental infections.
Figure 1: Depicting how infections affect pregnancy outcomes and the placental defence mechanisms. On the left, infections from sources like STDs, bacterial vaginosis, and dysbiotic microbiota activate Toll-like receptors (TLRs), leading to the release of pro-inflammatory cytokines (IL1β, IL6, IL8, TNFα, CCL2). This shifts the immune response from tolerogenic to immunogenic, resulting in foetal injuries, membrane rupture, and possibly miscarriage or preterm birth. On the right, the placenta defends against infections using exosomes, cytokines, and antimicrobial peptides. However, pathogens like Zika, Toxoplasma gondii, and Listeria monocytogenes can breach these defences, causing vertical transmission and placental damage due to an aberrant pro-inflammatory response 10 .
Current Research and Challenges
Several charitable organizations, such as March of Dimes and Tommy's in the UK, are dedicated to improving pregnancy health and reducing the incidence of birth defects, including those caused by placental infections. These organizations play a crucial role in funding research, raising awareness, and providing support to affected families.
Current research on placental infections utilizes advanced technologies to elucidate molecular mechanisms and develop targeted therapies. High-resolution imaging, single-cell sequencing, and organoid models provide deeper insights into infection processes, in which these methods enable detailed study of pathogen-host interactions, cellular responses, and potential intervention points 17 . Detection methods include non-invasive prenatal testing (NIPT), amniocentesis, and chorionic villus sampling, although these methods involve ethical considerations and potential risks. Researchers are leveraging genomics, proteomics, and transcriptomics to better understand placental invasion and immune evasion strategies of pathogens 5 . This comprehensive approach aims to enhance diagnostic accuracy and develop specific treatments while carefully navigating the complex ethical landscape of prenatal testing and intervention.
Conclusion and Future Directions
Understanding pathogen-placenta interactions is pivotal for developing effective strategies against placental infections. Recent advances in molecular and cellular biology have shed light on the complex maternal-foetal interface, paving the way for targeted interventions. Future research should prioritize enhancing preventive measures, refining early detection techniques, and exploring safe treatment options during pregnancy. Key focus areas include further elucidating on placental invasion mechanisms, improving placental barrier function, and identifying non-invasive biomarkers. Advanced technologies, such as organoid models and artificial intelligence (AI) offer promising avenues for drug screening and predictive diagnostics 2 . Translational research will be vital in bridging laboratory findings with clinical practice, leading to evidence-based guidelines for managing placental infections 3 .
As our understanding deepens, we move closer to more effective strategies for ensuring healthy pregnancies and positive outcomes for both mothers and their children. This multi-faceted approach holds the potential to significantly reduce the burden of placental infections and their associated complications.
References
Acosta-Reyes, J., Navarro, E., Herrera, M. J., Goenaga, E., Ospina, M. L., Parra, E., Mercado, M., Chaparro, P., Beltran, M., Gunturiz, M. L., Pardo, L., Valencia, C., Huertas, S., Rodríguez, J., Ruiz, G., Valencia, D., Haddad, L. B., Tinker, S. C., Moore, C. A., & Baquero, H. (2017). Severe Neurologic Disorders in 2 Fetuses with Zika Virus Infection, Colombia. Emerging infectious diseases , 23 (6), 982-984. https://doi.org/10.3201/eid2306.161702
Bai, L., Wu, Y., Li, G., Zhang, W., Zhang, H., & Su, J. (2024). AI-enabled organoids: Construction, analysis, and application. Bioactive Materials , 31 , 525-548. https://doi.org/https://doi.org/10.1016/j.bioactmat.2023.09.005
Bauman, M. D., & Van de Water, J. (2020). Translational opportunities in the prenatal immune environment: Promises and limitations of the maternal immune activation model. Neurobiol Dis , 141 , 104864. https://doi.org/10.1016/j.nbd.2020.104864
Burton, G. J., & Fowden, A. L. (2015). The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci , 370 (1663), 20140066. https://doi.org/10.1098/rstb.2014.0066
Choi, S., Khan, T., Roberts, R. M., & Schust, D. J. (2022). Leveraging Optimized Transcriptomic and Personalized Stem Cell Technologies to Better Understand Syncytialization Defects in Preeclampsia [Review]. Frontiers in Genetics , 13 . https://doi.org/10.3389/fgene.2022.872818
Deganich, M., Boudreaux, C., & Benmerzouga, I. (2023). Toxoplasmosis Infection during Pregnancy. Tropical Medicine and Infectious Disease , 8 (1).
Eallonardo, S. J., & Freitag, N. E. (2024). Crossing the Barrier: A Comparative Study of Listeria monocytogenes and Treponema pallidum in Placental Invasion. Cells , 13 (1).
Johnson, L. J., Azari, S., Webb, A., Zhang, X., Gavrilin, M. A., Marshall, J. M., Rood, K., & Seveau, S. (2021). Human Placental Trophoblasts Infected by Listeria monocytogenes Undergo a Pro-Inflammatory Switch Associated With Poor Pregnancy Outcomes [Original Research]. Frontiers in Immunology , 12 . https://doi.org/10.3389/fimmu.2021.709466
Kato, K. (2018). How does <i>Toxoplama gondii</i> invade host cells? Journal of Veterinary Medical Science , 80 (11), 1702-1706. https://doi.org/10.1292/jvms.18-0344
Kumar, M., Saadaoui, M., & Al Khodor, S. (2022). Infections and Pregnancy: Effects on Maternal and Child Health [Review]. Frontiers in Cellular and Infection Microbiology , 12 . https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2022.873253
Li, X., Li, Z.-H., Wang, Y.-X., & Liu, T.-H. (2023). A comprehensive review of human trophoblast fusion models: recent developments and challenges. Cell Death Discovery , 9 (1), 372. https://doi.org/10.1038/s41420-023-01670-0
MacIntyre, D. A., Chandiramani, M., Lee, Y. S., Kindinger, L., Smith, A., Angelopoulos, N., Lehne, B., Arulkumaran, S., Brown, R., Teoh, T. G., Holmes, E., Nicoholson, J. K., Marchesi, J. R., & Bennett, P. R. (2015). The vaginal microbiome during pregnancy and the postpartum period in a European population. Scientific reports , 5 (1), 8988. https://doi.org/10.1038/srep08988
Megli, C. J., & Coyne, C. B. (2022). Infections at the maternal–fetal interface: an overview of pathogenesis and defence. Nature Reviews Microbiology , 20 (2), 67-82. https://doi.org/10.1038/s41579-021-00610-y
Narang, K., Cheek, E. H., Enninga, E. A. L., & Theiler, R. N. (2021). Placental Immune Responses to Viruses: Molecular and Histo-Pathologic Perspectives. International journal of molecular sciences , 22 (6).
Pontes, K. F., Nardozza, L. M., Peixoto, A. B., Werner, H., Tonni, G., Granese, R., & Araujo Júnior, E. (2024). Cytomegalovirus and Pregnancy: A Narrative Review. Journal of Clinical Medicine , 13 (2).
Silini, A. R., Di Pietro, R., Lang-Olip, I., Alviano, F., Banerjee, A., Basile, M., Borutinskaite, V., Eissner, G., Gellhaus, A., Giebel, B., Huang, Y.-C., Janev, A., Kreft, M. E., Kupper, N., Abadía-Molina, A. C., Olivares, E. G., Pandolfi, A., Papait, A., Pozzobon, M., . . . Parolini, O. (2020). Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature [Review]. Frontiers in bioengineering and biotechnology , 8 . https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2020.610544
Zhao, Z., Chen, X., Dowbaj, A. M., Sljukic, A., Bratlie, K., Lin, L., Fong, E. L. S., Balachander, G. M., Chen, Z., Soragni, A., Huch, M., Zeng, Y. A., Wang, Q., & Yu, H. (2022). Organoids. Nature Reviews Methods Primers , 2 (1), 94. https://doi.org/10.1038/s43586-022-00174-y